SCHEMBL6424332

SCHEMBL6424332

CSc1ccc(C(=O)n2c(C)c(CC(=O)O)c3cc(O)c(F)cc32)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 8/20 0.55
AKR1C2 P52895 8/20 0.55
PTGS2 P35354 6/20 0.53
PTGS1 P23219 4/20 0.53
ABCB1 P08183 3/20 0.48
LMNA P02545 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2D6 P10635 2/20 0.48
CYP2C9 P11712 2/20 0.48
HIF1A Q16665 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
AKR1C4 P17516 2/20 0.48
AKR1C1 Q04828 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
PTGES O14684 1/20 0.48
ABCC3 O15438 1/20 0.48
ABCC4 O15439 1/20 0.48
ABCB11 O95342 1/20 0.48
MT-CO2 P00403 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5439139 0.89 AKR1C3 (0.62) AKR1C3AKR1C2PTGS2PTGS1ABCB1
SCHEMBL5447453 0.89 AKR1C3 (0.66) AKR1C3AKR1C2PTGS2PTGS1ABCB1
SCHEMBL5443931 0.89 PTGS1 (0.64) AKR1C3AKR1C2PTGS2PTGS1ABCB1
SCHEMBL5439231 0.89 AKR1C3 (0.53) AKR1C3AKR1C2PTGS2PTGS1ABCB1
SCHEMBL5438248 0.89 AKR1C3 (0.53) AKR1C3AKR1C2PTGS2PTGS1ABCB1
SCHEMBL3001769 0.88 LMNA (0.61) AKR1C3AKR1C2PTGS2PTGS1ABCB1
SCHEMBL5452299 0.87 AKR1C3 (0.51) AKR1C3AKR1C2PTGS2PTGS1ABCB1
SCHEMBL5445915 0.87 AKR1C3 (0.57) AKR1C3AKR1C2PTGS2PTGS1ABCB1
SCHEMBL2000986 0.87 AKR1C3 (0.72) AKR1C3AKR1C2PTGS2PTGS1ABCB1
SCHEMBL6423751 0.87 PTGS2 (0.63) AKR1C3AKR1C2PTGS2PTGS1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 AKR1C3 577/4885AKR1C2 563/4885PTGS2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.